ArticleExperimental hematology & oncology2026
CD84 expression stratifies venetoclax response and reveals a targetable vulnerability in resistant acute myeloid leukemia.
Xuemei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.